GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
23:40 Apr 7, 2007 |
English to Croatian translations [PRO] Medical - Medical: Pharmaceuticals / Clinical trial | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Davorka Grgic Local time: 01:43 | ||||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
4 +3 | koji ranije nisu uzimali ispitivani lijek / aktivnu tvar |
| ||
3 -1 | asimptomatski, oboleli bez simptoma bolesti |
|
naive koji ranije nisu uzimali ispitivani lijek / aktivnu tvar Explanation: ...kod njih je obicno jaci ucinak lijeka. Mozda "bez iskustva uzimanja" ili nesto slicno. Nisam uspjela naci referencu na hrv. Drug works in treatment-naive, experienced patients.[No authors listed] AIDS: ABT-378, a new drug from Abbott Laboratories, may hold promise for patients who are infected with drug-resistant HIV. ABT-378 made in a combination pill with ritonavir can suppress HIV viral loads to fewer than 400 copies/mL in 78 percent of protease inhibitor-experienced patients and 95 percent of treatment-naive patients. It is well tolerated, with the most common side effects being diarrhea, nausea, asthenia, and headaches. It is taken twice a day in a single pill; researchers are evaluating the effectiveness of taking it only once a day. PMID: 11366988 [PubMed - indexed for MEDLINE] Reference: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d... |
| |
Grading comment
| ||